|
Strides Pharma Science Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
6003.02 Cr.
|
P/BV
|
2.64
|
Book Value (Rs.)
|
246.48
|
|
52 Week High/Low (Rs.)
|
1675/513
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
09/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.38
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 3374.94 | 2967.09 | 2702.02 | 2204.23 | 2407.38 |
| Total Income From Operations | 3374.94 | 2967.09 | 2702.02 | 2204.23 | 2407.38 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 1206.16 | 987.28 | 1173.28 | 921.75 | 987.66 |
| Purchase of Traded Goods | 456.49 | 170.81 | 119.28 | 198.71 | 180.32 |
| Increase/Decrease in Stocks | -181.65 | 66.20 | -66.37 | -45.62 | -206.70 |
| Employees Cost | 639.89 | 551.96 | 556.36 | 489.66 | 396.45 |
| Depreciation | 143.40 | 170.92 | 182.32 | 172.34 | 154.43 |
| Other Expenses | 669.10 | 677.32 | 644.85 | 702.01 | 572.06 |
| Total Expenses | 2933.40 | 2624.48 | 2609.72 | 2438.84 | 2084.21 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 441.54 | 342.61 | 92.30 | -234.61 | 323.16 |
| Other Income | 46.74 | 53.25 | 63.21 | 45.93 | 38.38 |
| P/L Before Interest, Excpt. Items & Tax | 488.29 | 395.85 | 155.51 | -188.68 | 361.54 |
| Interest | 198.53 | 234.29 | 180.63 | 127.26 | 108.46 |
| P/L Before Exceptional Items & Tax | 289.76 | 161.57 | -25.12 | -315.94 | 253.09 |
| Exceptional Items | 92.08 | -180.97 | -9.69 | -166.88 | 44.29 |
| P/L Before Tax | 381.83 | -19.41 | -34.81 | -482.82 | 297.37 |
| Tax | 56.76 | 12.34 | -62.39 | -46.78 | 20.16 |
| P/L After Tax from Ordinary Activities | 325.08 | -31.75 | 27.58 | -436.04 | 277.21 |
| Extra Ordinary Item | 3188.11 | 54.15 | 18.57 | 0.00 | 14.77 |
| Net Profit/Loss For the Period | 3513.18 | 22.40 | 46.15 | -436.04 | 291.98 |
| Share Of P/L Of Associates | -1.29 | -127.16 | -244.68 | -67.17 | -78.00 |
| Net P/L After Minority Interest & Share Of Associates | 3511.89 | -104.76 | -198.54 | -503.21 | 213.99 |
| | | | | | |
| Equity Share Capital | 92.16 | 91.89 | 90.30 | 89.78 | 89.63 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 381.81 | -9.79 | -21.45 | -54.54 | 24.82 |
| Diluted EPS (Rs.) | 381.77 | -9.79 | -21.45 | -54.54 | 24.79 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 381.81 | -9.79 | -21.45 | -54.54 | 24.82 |
| Diluted EPS (Rs.) | 381.77 | -9.79 | -21.45 | -54.54 | 24.79 |
| | | | | | |
| PBITOE Margin (%) | 13.08 | 11.54 | 3.41 | -10.64 | 13.42 |
| PBTE Margin (%) | 8.58 | 5.44 | -0.92 | -14.33 | 10.51 |
| PBT Margin (%) | 11.31 | -0.65 | -1.28 | -21.90 | 12.35 |
| PAT Margin (%) | 104.09 | 0.75 | 1.70 | -19.78 | 12.12 |
| PAT After MI And SOA Margin (%) | 104.05 | -3.53 | -7.34 | -22.82 | 8.88 |
